National Research (NASDAQ:NRC) Earns "Sell (D+)" Rating from Weiss Ratings

Key Points

• National Research (NASDAQ:NRC) has been reaffirmed with a "sell (D+)" rating by Weiss Ratings, indicating a cautionary outlook for investors.
• The company's stock price has decreased by 0.1%, reaching $11.47, with a market cap of $264.52 million and a price-to-earnings ratio of 15.12.
• Recent activity shows institutional investors have been increasing their stakes significantly, with EverSource Wealth Advisors increasing their stake by 9,535.3% in the second quarter.

National Research (NASDAQ:NRC - Get Free Report)'s stock had its "sell (d+)" rating reaffirmed by Weiss Ratings in a note issued to investors on Tuesday,Weiss Ratings reports.

National Research Stock Down 0.1%

Shares of NRC traded down $0.01 during midday trading on Tuesday, reaching $11.47. The stock had a trading volume of 49,042 shares, compared to its average volume of 94,237. National Research has a 1-year low of $9.76 and a 1-year high of $21.64. The company's fifty day simple moving average is $14.51 and its two-hundred day simple moving average is $14.09. The company has a market cap of $264.52 million, a price-to-earnings ratio of 15.12 and a beta of 0.41. The company has a debt-to-equity ratio of 3.61, a current ratio of 0.70 and a quick ratio of 0.70.

National Research (NASDAQ:NRC - Get Free Report) last announced its quarterly earnings data on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%. The business had revenue of $34.04 million for the quarter.

Institutional Investors Weigh In On National Research

Hedge funds and other institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC raised its stake in National Research by 9,535.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company's stock worth $28,000 after acquiring an additional 1,621 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in National Research during the 2nd quarter worth $34,000. PNC Financial Services Group Inc. raised its stake in National Research by 1,072.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,087 shares of the company's stock worth $35,000 after acquiring an additional 1,909 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in National Research by 284.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,514 shares of the company's stock worth $42,000 after acquiring an additional 1,860 shares in the last quarter. Finally, Strs Ohio purchased a new position in National Research during the 1st quarter worth $33,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.